[HTML][HTML] Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

…, K Ng, S Basra, LY Lim, R Kalikawe, S Speckmaier… - npj Vaccines, 2022 - nature.com
Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …

[HTML][HTML] SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells

…, MC Duncan, HR Lapointe, S Speckmaier… - Nature …, 2022 - nature.com
Efforts to cure HIV have focused on reactivating latent proviruses to enable elimination by
CD8 + cytotoxic T-cells. Clinical studies of latency reversing agents (LRA) in antiretroviral …

[HTML][HTML] People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose …

…, F Yaseen, G Umviligihozo, R Kalikawe, S Speckmaier… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a third …

People with human immunodeficiency virus receiving suppressive antiretroviral therapy show typical antibody durability after dual coronavirus disease 2019 …

…, R Kalikawe, S Speckmaier… - The Journal of …, 2023 - academic.oup.com
Background Longer-term humoral responses to 2-dose coronavirus disease 2019 (COVID-19)
vaccines remain incompletely characterized in people living with human …

[HTML][HTML] Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

…, PK Cheung, Y Sang, F Yaseen, S Speckmaier… - Aids, 2023 - journals.lww.com
Background: Limited data exist regarding longer term antibody responses following three-dose
coronavirus disease 2019 (COVID-19) vaccination, and the impact of a first SARS-CoV-2 …

[HTML][HTML] SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy

…, Y Sang, S Ennis, F Mwimanzi, S Speckmaier… - Aids, 2023 - journals.lww.com
Objective: Limited data exist regarding the immune benefits of fourth COVID-19 vaccine doses
in people with HIV (PWH) receiving antiretroviral therapy (ART), particularly now that most …

T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy

…, FH Omondi, MC Duncan, E Barad, S Speckmaier… - Viruses, 2024 - mdpi.com
People living with HIV (PLWH) can exhibit impaired immune responses to vaccines.
Accumulating evidence indicates that PLWH, particularly those receiving antiretroviral therapy, …

[HTML][HTML] Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults

…, R Kalikawe, F Mwimanzi, S Speckmaier… - Pathogens and …, 2023 - ncbi.nlm.nih.gov
Methods: We quantified CD4+ and CD8+ T-cells reactive to overlapping peptides spanning
the ancestral SARS-CoV-2 spike protein in 40 older adults (median age 79) and 50 younger …

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size

…, FH Omondi, NN Kinloch, HR Lapointe, S Speckmaier… - AIDS, 2022 - journals.lww.com
Objective: The immunogenic nature of COVID-19 mRNA vaccines led to some initial concern
that these could stimulate the HIV reservoir. We analyzed changes in plasma HIV loads (…

The effect of temperature on the growth rate of Euglena gracilis

S Ko, S Speckmaier, N Wang - The Expedition, 2019 - ojs.library.ubc.ca
Climate change is linked to a rise in global temperatures, which affects many organisms that
are sensitive to these changes. The objective of our study was to investigate the effect of …